GM-CSF administration for the treatment and prevention of recurr

Details GM-CSF administration for the treatment and prevention of recurr GM-CSF administration for the treatment and prevention of recurr

1996-06-27

1998-11-17

Feisee, Lila

Drug, bio-affecting and body treating compositions

Lymphokine

4242771, 424 937, 514 2, A61K 3819, A61K 3512, A61K 3800

Patent

active

058372318

ABSTRACT:
A method for inhibiting the growth of brain tumors comprising peripheral administration of GM-CSF in combination with brain tumor antigen.

REFERENCES:
patent: 5165922 (1992-11-01), Hellstrom et al.
patent: 5208022 (1993-05-01), Eggers
Pardoll, DM. 1995, Annu. Rev. Immunol. 13:399-415.
Wakinoto, H et al. 1996. Cancer Res. 56:1828-33.
Sampson, JH. et al. 1996. Proceed. Amer. Assoc. Cancer Res. 37:339.
Ellem, K. AO. 1997. Cancer Immunol. Immunother. 44:10-20.
Coleman, et al. The Journal of Immunology, 143:4134-4140(Dec. 15, 1989).
Colombo, et al. J. Exp. Med., 173:889-897(Apr. 1991).
Falk, et al. Journal of Leukocyte Biology, 43:471-476(1988).
Grabstein, et al. Science, 232:506-508 (Apr. 25, 1986).
Heufler, et al. J. Exp. Med., 167:700-705(Feb. 1988).
Markowicz, et al. J. Clin. Invest., 85:955-961 (Mar. 1990).
Witmer-Pack, et al. J. Exp. Med., 166:1484-1498 (Nov. 1987).
Abe, et al., Cancer Gene Therapy, 1:312 (1994).
Anderson, Science, 256:808-813 (May 8, 1992).
Asher, et al., The Journal of Immunology, 146:3227-3234 (May 1, 1991).
Blankenstein, et al., J. Exp. Med., 17:1047-1052 (May 1991).
Dranoff, et al., Proc. Natl. Acad. Sci. USA, 90:3539-3543 (Apr. 1993).
Elliot, et al., J. Clin. Invest., 86:80-86 Jul. 1990).
Elliott, et al., J. Neurosurgery, 67:231-236 (Aug. 1987).
Fearon, et al., Cell, 60:397-403 (Feb. 9, 1990).
Fontana, et al., J. Immunol., 132:1837-1844 (Apr. 1984).
Frei, Neuropathology and Applied Neurobiology, 20:206-208 (1994).
Gansbacher, et al., Cancer Research, 50:7820-7825 (Dec. 15, 1990).
Gansbacher, et al., J. Exp. Med., 172:1217-1224 (Oct. 1990).
Hock, et al., J. Exp. Med., 174:1291-1298 (Dec. 1991).
Holladay, et al., J. Neurosurgery, 80:90-96 (Jan. 1994).
Inaba, et al., J. Exp. Med., 176:1693-1702 (Dec. 1992).
Kampgen, et al., J. Exp. Med., 179:1767-1776 (Jun. 1994).
King, et al., Immunology Today, 11:206-211 (1990).
Kurpad, et al., Seminars in Oncology, 21:149-161 (Apr. 1994).
Lampson, et al., J. Immunol., 136:4054-4062 (Jun. 1, 1986).
Lee, et al., J. Clin. Oncol., 7:7-20 (Jan. 1989).
Levin, et al., in Cancer Principles and Practice of Oncology, V. T. DeVita, et al., eds., J. B. Lippincott Co., Philadelphia, PA, 2:1679-1737 (1993).
Mahaley, et al., J. Neurosurgery, 71:826-836 (Dec. 1989).
Morioka, et al., Neurosurgery, 30:891-896 (1992).
Morioka, et al., Acta Neuropathol., 83:590-597 (1992).
Myers, et al., J. Neurosurg., 76:986-990 (Jun. 1992).
Paglia, et al., J. Exp. Med., 178:1893-1901 (Dec. 1993).
Porgador, et al., Cancer Research, 52:3679-3686 (Jul. 1, 1992).
Reid, et al., The Journal of Immunology, 149:2681-2688 (Oct. 15, 1992).
Restifo, et al., The Journal of Exp. Med., 175:1423-1431 (Jun. 1992).
Rosenberg, et al., N. Engl. J. Med., 316:889-897 (Apr. 9, 1987).
Roszman, et al., Immunology Today, 12:370-374 (1991).
Sanda, et al., The Journal of Urology, 151:622-628 (Mar. 1994).
Schwyzer, et al., J. Immunol., 134:1003-1009 (Feb. 1985).
Steinman, Annu. Rev. Immunol., 9:271-296 (1991).
Tada, et al., Journal of Neuro-Oncology, 17:261-271 (1993).
Tzeng, et al., Cancer Res., 50:4338-4343 (Jul. 15, 1990).
Urbani, et al., Journal of Interferon and Cytokine Research, 15:421-429 (1995).
Watanabe, et al., Proc. Natl. Acad. Sci. USA, 86:9456-9460 (Dec. 1989).
Wen, et al., J. Neuroimmunol., 36:57-68 (1992).
Osband, M.E. 1990 Immunology Today 11:193-195.
Disis, M.L et al. 1995. 9.sup.th Duterudtl. Congress Immunology, 582.
Stevenson, F.K. et al. 1995 Immunol. Review, 145:211-228.

Affiliated with

Also associated with

Rating

GM-CSF administration for the treatment and prevention of recurr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GM-CSF administration for the treatment and prevention of recurr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GM-CSF administration for the treatment and prevention of recurr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-881290